These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 28230534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
    Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF.
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
    Alinejad V, Hossein Somi M, Baradaran B, Akbarzadeh P, Atyabi F, Kazerooni H, Samadi Kafil H, Aghebati Maleki L, Siah Mansouri H, Yousefi M.
    Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
    [Abstract] [Full Text] [Related]

  • 4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X, Wang Q, Qin L, Fu H, Fang Y, Han B, Duan Y.
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [Abstract] [Full Text] [Related]

  • 5. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.
    Biomacromolecules; 2009 Jan 12; 10(1):41-8. PubMed ID: 19072631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
    Wu X, Zheng Y, Yang D, Chen T, Feng B, Weng J, Wang J, Zhang K, Zhang X.
    J Mater Chem B; 2019 Jan 21; 7(3):477-487. PubMed ID: 32254735
    [Abstract] [Full Text] [Related]

  • 8. Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.
    Ebrahimian M, Taghavi S, Mokhtarzadeh A, Ramezani M, Hashemi M.
    Appl Biochem Biotechnol; 2017 Sep 21; 183(1):126-136. PubMed ID: 28236188
    [Abstract] [Full Text] [Related]

  • 9. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X.
    Biomaterials; 2011 Mar 21; 32(8):2222-32. PubMed ID: 21186059
    [Abstract] [Full Text] [Related]

  • 10. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
    Qian J, Xu M, Suo A, Xu W, Liu T, Liu X, Yao Y, Wang H.
    Acta Biomater; 2015 Mar 21; 15():102-16. PubMed ID: 25545322
    [Abstract] [Full Text] [Related]

  • 11. Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro.
    Koehler BC, Scherr AL, Lorenz S, Urbanik T, Kautz N, Elssner C, Welte S, Bermejo JL, Jäger D, Schulze-Bergkamen H.
    PLoS One; 2013 Mar 21; 8(10):e76446. PubMed ID: 24098503
    [Abstract] [Full Text] [Related]

  • 12. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of antiapoptotic Bcl-xL and survivin in combination with chemotherapy.
    Kunze D, Erdmann K, Froehner M, Wirth MP, Fuessel S.
    Int J Mol Sci; 2013 Jun 07; 14(6):12297-312. PubMed ID: 23749114
    [Abstract] [Full Text] [Related]

  • 13. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
    Antonietti P, Gessler F, Düssmann H, Reimertz C, Mittelbronn M, Prehn JH, Kögel D.
    Biochim Biophys Acta; 2016 Apr 07; 1863(4):499-509. PubMed ID: 26721623
    [Abstract] [Full Text] [Related]

  • 14. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y, Dai W, Nevagi RJ, Toth I, Moyle PM.
    Acta Biomater; 2017 Sep 01; 59():257-268. PubMed ID: 28655658
    [Abstract] [Full Text] [Related]

  • 15. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.
    Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, Arun B, Lopez-Berestein G, Ozpolat B.
    Autophagy; 2008 Jul 01; 4(5):669-79. PubMed ID: 18424910
    [Abstract] [Full Text] [Related]

  • 16. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
    Aliabadi HM, Mahdipoor P, Uludağ H.
    Cancer Gene Ther; 2013 Mar 01; 20(3):169-77. PubMed ID: 23449477
    [Abstract] [Full Text] [Related]

  • 17. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
    Kim DW, Seo SW, Cho SK, Chang SS, Lee HW, Lee SE, Block JA, Hei TK, Lee FY.
    J Orthop Res; 2007 Jun 01; 25(6):820-8. PubMed ID: 17343283
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, Xiao X, Yang Y, Sheng W, Wu Y, Zeng Y.
    Biomaterials; 2014 May 01; 35(14):4333-44. PubMed ID: 24565525
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
    Guruprasath P, Kim J, Gunassekaran GR, Chi L, Kim S, Park RW, Kim SH, Baek MC, Bae SM, Kim SY, Kim DK, Park IK, Kim WJ, Lee B.
    Biomaterials; 2017 Oct 01; 142():101-111. PubMed ID: 28732245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.